North America High-Flow Nasal Cannula Market to 2027- Regional Analysis and Forecasts by Component (Air Oxygen Blender, Nasal Cannula, Heated Inspiratory Circuit, and Active Humidifier); Application (Bronchiectasis, Acute Respiratory Failure, Acute Heart Failure, and Chronic Obstructive Pulmonary Disease); End User (Ambulatory Care Centers, Hospitals and Long-Term Care Centers) and Country
- THE3479213
- 130 Pages
- January 2020
- Medical Devices
The growth of the market is majorly contributed by increasing government initiatives and growing asthma cases. However, adverse effects or risk of high flow nasal cannula is likely to have a negative impact on the growth of the market in the coming years.
In the US, cases of asthma and chronic obstructive pulmonary disease (COPD) are the significant public health burdens. Governments are, therefore, taking initiatives and patient-centric national guidelines for COPD that are accessible and easy to follow by healthcare professionals. For instance, with existing COPD guidelines, the American Thoracic Society (ATS) and the global initiative for Chronic Lung Disease (GOLD), creates clinical practice guidelines that set consistent national standards for identifying people at risk for COPD as well as diagnosing and treating people with COPD across the care continuum. Additionally, significant funding is provided to ensure that quality clinical research is conducted into chronic respiratory conditions, and to maintain national monitoring and surveillance measures.
In 2018, the US high-flow nasal cannula market held the largest share of the North America high-flow nasal cannula market because it has highest COPD prevalence. During the year 2013 to 2017, an estimated 2.4 million U.S. working adults aged above 18 years had COPD who never smoked. The highest COPD prevalence among non-smokers were in the information (3.3%) and mining (3.1%) industries and office and administrative support occupation workers (3.3%).
The hospital segment expected to dominate the North America high-flow nasal cannula market. Additionally, this segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027. Similarly, in 2018 the active humidifier segment held the major market share among the component segments.
By Component, the active humidifier segment held a largest market share of the high-flow nasal cannula market, in 2018. The active humidifier is expected to dominate its market share in 2027 because for invasive and non-invasive ventilation, there are many players who provide this by heated circuits and systems. The active humidifier segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.
Chronic Obstructive Pulmonary Disease segment a largest market share of the high-flow nasal cannula market, by application in 2018. However, bronchiectasis segment expected to have largest market in 2027 because patients with bronchiectasis are growing consistently since 2001 and its prevalence is more in elder population.
Some of the major primary and secondary sources for drug delivery systems included in the report are the American Thoracic Society (ATS) and the global initiative for Chronic Lung Disease (GOLD), NCD Alliance, etc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. North America High-Flow Nasal Cannula Market – Key Takeaways
3. North America High-Flow Nasal Cannula Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 North America High-Flow Nasal Cannula Market – By Component
3.2.2 North America High-Flow Nasal Cannula Market – By Application
3.2.3 North America High-Flow Nasal Cannula Market – By End User
3.2.4 North America High-Flow Nasal Cannula Market – By North America Countries
3.3 PEST Analysis
4. North America High-Flow Nasal Cannula Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Lung Cancer Conferences Across North America
4.1.2 Growing Asthma Cases in Adults and Children
4.2 Key Market Restraints
4.2.1 Side Effects Associated with High Flow Nasal Cannula
4.3 Key Market Opportunity
4.3.1 Growing Geriatric Population
4.4 Future Trend
4.4.1 Increasing Acceptance of Home Oxygen Therapy
4.5 Impact Analysis
5. High-Flow Nasal Cannula Market – North America Analysis
5.1 North America High-Flow Nasal Cannula Market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 Performance of Key Players
5.3.1 Fisher & Paykel Healthcare Limited
5.3.2 ResMed
6. North America High-Flow Nasal Cannula Market Analysis – By Component
6.1 Overview
6.2 Component market Revenue and Forecasts Analysis (US$ Mn)
6.3 Air Oxygen Blender
6.3.1 Overview
6.3.2 North America Air Oxygen Blender Market Revenue and Forecast to 2027 (US$ Mn)
6.4 Nasal Cannula
6.4.1 Overview
6.4.2 North America Nasal Cannula Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Heated Inspiratory Circuit
6.5.1 Overview
6.5.2 North America Heated Inspiratory Circuit Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Active Humidifier
6.6.1 Overview
6.6.2 North America Active Humidifier Market Revenue and Forecast to 2027 (US$ Mn)
7. North America High-Flow Nasal Cannula Market Analysis – By Application
7.1 Overview
7.2 North America High-Flow Nasal Cannula Market, by Application 2018 & 2027 (%)
7.3 Bronchiectasis
7.3.1 Overview
7.3.2 North America Bronchiectasis Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Acute Respiratory Failure
7.4.1 Overview
7.4.2 North America Acute Respiratory Failure Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Acute Heart Failure
7.5.1 Overview
7.5.2 North America Acute Heart Failure Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Chronic Obstructive Pulmonary Disease
7.6.1 Overview
7.6.2 North America Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2027 (US$ Mn)
8. North America High-Flow Nasal Cannula Market Analysis – By End User
8.1 Overview
8.2 North America High-Flow Nasal Cannula Market, by Applicaton 2018 & 2027 (%)
8.3 Ambulatory Surgical Centers
8.3.1 Overview
8.3.2 North America Ambulatory Surgical Centers Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hospitals
8.4.1 Overview
8.4.2 North America Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Long-Term Care Centers
8.5.1 Overview
8.5.2 North America Long-Term Care Centers Market Revenue and Forecast to 2027 (US$ Mn)
9. North America High-Flow Nasal Cannula Market Revenue And Forecasts To 2027
9.1 North America High-Flow Nasal Cannula Market
9.1.1 Overview
9.1.2 North America High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.3 North America High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.4 North America High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.5 North America High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.6 North America High-Flow Nasal Cannula Market Revenue and Forecasts to 2027, By Country (%)
9.1.7 Germany
9.1.7.1 Germany High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Germany High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.7.3 Germany High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.7.4 Germany High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.8 UK
9.1.8.1 UK High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 UK High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.8.3 UK High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.8.4 UK High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.9 France
9.1.9.1 France High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.2 France High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.9.3 France High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.9.4 France High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.10 Spain
9.1.10.1 Spain High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.2 Spain High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.10.3 Spain High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.10.4 Spain High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.11 Italy
9.1.11.1 Italy High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11.2 Italy High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.11.3 Italy High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.11.4 Italy High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. High-Flow Nasal Cannula Market –Industry Landscape
10.1 Overview
10.1.1 Recent Developments by Players in the High-Flow Nasal Cannula Market
11. High-Flow Nasal Cannula Market–Key Company Profiles
11.1 Fisher & Paykel Healthcare Limited
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 ResMed.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Teleflex Incorporated
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Information
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Hamilton Company
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Great Group Medical Co., Ltd.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Information
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Salter Labs (SunMed, LLC)
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 TNI medical AG.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Flexicare (Group) Limited
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Vapotherm
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 MEK-ICS CO., LTD.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Solution Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
12.3 Methodology
12.4 Coverage
12.5 Secondary Research
12.6 Primary Research
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
